Status:
RECRUITING
An Extension Test of Whether to Use Oral Anti-anxiety Drugs (XANAX) When Patients Choose Second Eye Cataract Surgery After Unblinding, and Analyze Their Anxiety, Satisfaction and Pain Satisfaction
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Ophthalmology
Cataract Surgery Anesthesia
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
Phacoemulsification is one of the most used surgical methods for cataract surgery today, and the surgeries are under the anesthetic and sedative to make it comfortable and safe for patients. The most ...
Detailed Description
BACKGROUNDS Nowadays, phacoemulsification for cataract treatment is the most common surgical procedure performed and anesthetics procedure has been shifted from retrobulbar or peribulbar anesthesia to...
Eligibility Criteria
Inclusion
- Age between 18 and 80 years old.
- Enrolled in "Anxiety and surgery satisfaction for cataract patient with different state anxiety" (Research Ethics Committee Case No.: 202302067MINB).
- Plan to undergo phacoemulsification and intraocular lens implantation surgery with topical anesthetic on the second eye at the Department of Ophthalmology.
- Subject who does not have side effect from XANAX.
Exclusion
- Presence of any surgery contraindications.
- Presence of any medication contraindications.
- Inability to provide clear and complete answers to relevant questionnaires, or expression of no preoperative anxiety during the outpatient visit, or scores below 21 on the STAI-S or STAI-T assessment.
- Regular use of anti-anxiety medications, sleeping pills, or analgesics before the procedure.
- Pregnancy or breastfeeding during the preoperative period.
- Severe corneal diseases, overripe cataracts, small pupils, or lens dislocation leading to difficulties in conventional surgery.
- Patients under surface anesthesia who cannot fully cooperate with the surgical procedure.
- Pregnant or uncertain pregnancy status (women under 55 years old to be verbally asked by research team members).
Key Trial Info
Start Date :
March 25 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06874452
Start Date
March 25 2025
End Date
December 31 2027
Last Update
November 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100